Research Nester Logo.jpg
Cholangiocarcinoma Market revenue to hit USD 1.3 Billion by 2036, says Research Nester
07 déc. 2023 06h30 HE | Research Nester
New York , Dec. 07, 2023 (GLOBE NEWSWIRE) -- The global cholangiocarcinoma market size is projected to grow at a CAGR of over 4% from 2024 to 2036. The market is expected to garner a revenue of USD...
Logo.png
Intrahepatic Cholangiocarcinoma Clinical Trial Pipeline Shows Rapid Progress with 20+ Companies Working to Develop Therapies, Assesses DelveInsight
06 avr. 2022 13h00 HE | DelveInsight Business Research LLP
New York, USA, April 06, 2022 (GLOBE NEWSWIRE) -- Intrahepatic Cholangiocarcinoma Clinical Trial Pipeline Shows Rapid Progress with 20+ Companies Working to Develop Therapies, Assesses DelveInsight ...
Logo.png
Cholangiocarcinoma Pipeline Insight: Therapeutic analysis of 70+ pipeline therapies and 70+ pharmaceutical companies 
16 mars 2021 21h20 HE | DelveInsight Business Research LLP
Los Angeles, USA, March 16, 2021 (GLOBE NEWSWIRE) -- Cholangiocarcinoma Pipeline Insight: Therapeutic analysis of 70+ pipeline therapies and 70+ pharmaceutical companies  Cholangiocarcinoma...